from the when-matter-becomes-software dept.
engeneOS in Cambridge, MA states in a press release: "The company is developing Engineered Genomic Operating Systems to enable the design and construction of programmable Biomolecular Machines employing natural and artificial building blocks. These Biomolecular Machines will serve a broad range of commercial applications including biosensors, chemical synthesis and processing, bio-electronic devices and materials, nanotechnology [emphasis added]…" CP: The team list is impressive.
